Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 20:00
Korro Bio Shareholders Equity (Quarterly): 198.08M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 198.08M |
| March 31, 2024 | 151.36M |
| September 30, 2023 | -153.26M |
| Date | Value |
|---|---|
| June 30, 2023 | -135.40M |
| December 31, 2022 | -99.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-153.26M
Minimum
Sep 2023
198.08M
Maximum
Jun 2024
-7.65M
Average
-99.03M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics Inc | 9.703M |
| Pliant Therapeutics Inc | 345.82M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.59M |
| Total Liabilities (Quarterly) | 51.51M |